Progress on the research of liver diseases in 2022.
10.3760/cma.j.cn501113-20221226-00611
- Author:
Xiao Guang DOU
1
;
Xiao Yuan XU
2
;
Yue Min NAN
3
;
Lai WEI
4
;
Tao HAN
5
;
Yi Min MAO
6
;
Ying HAN
7
;
Hong REN
8
;
Ji Dong JIA
9
;
Hui ZHUANG
10
Author Information
1. Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang 110022, China.
2. Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
3. Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
4. Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.
5. Tianjin Union Medicine Center, Nankai University Affiliated Hospital, Tianjin 300121, China.
6. Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China.
7. Department of Gastroenterology, the First Affiliated Hospital, Air Force Medical University, Xi'an 710032, China.
8. Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 401336, China.
9. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
10. Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
- Publication Type:Journal Article
- Keywords:
Autoimmune liver disease;
Drug-induced liver injury;
Fatty liver;
Hepatic fibrosis;
Hepatocellular carcinoma;
Liver cirrhosis;
Liver failure;
Liver transplantation;
Viral hepatitis
- MeSH:
Humans;
Liver Cirrhosis;
Liver Diseases;
Liver Neoplasms;
Carcinoma, Hepatocellular
- From:
Chinese Journal of Hepatology
2023;31(1):3-15
- CountryChina
- Language:Chinese
